Clinical trials help find new ways to prevent, detect and treat cancer. The UMMC Cancer Center and Research Institute joins other medical centers across the nation in the search for these medical advances and offers clinical trials when appropriate to adult and pediatric patients.
When researchers study the effectiveness of new therapies, patients participating in those clinical trials may be among the first to benefit from new medications or procedures.
UMMC works with several national study groups that offer clinical trials. UMMC also participates in studies sponsored by the National Cancer Institute’s National Clinical Trials Networks. National study groups include:
A physician may approach a patient if they believe that patient could benefit from a clinical trial, also called a study.
Only those patients who choose to participate are included in clinical trials. Those decisions are personal and often are made in hopes of a better therapy for the individual or to advance science for others.
Doctors and clinical trial nurses and coordinators explain the study in detail so the patient, or in the case of children, the parent, can make a fully informed decision about whether to participate. Once a patient decides to participate, they have the option of withdrawing at any time.
Patients in clinical trials are closely monitored by doctors, nurses and those who oversee the clinical trial. All are committed to protecting each patient’s safety and health during the study.